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Clinical Isolates of Salmonella enterica Serovar Agona Producing
NDM-1 Metallo--Lactamase: First Report from Pakistan
Seema Irfan,a Erum Khan,a Kauser Jabeen,a Pushpa Bhawan,a Katie L. Hopkins,b Martin Day,b Amna Nasir,a Daniele Meunier,b
Neil Woodfordb
Department of Pathology Microbiology, The Aga Khan University, Karachi, Pakistana; Antimicrobial Resistance and Healthcare-Associated Infections Reference Unit, Public
Health England, London, Englandb
We report two cases of infantile diarrhea due to multidrug-resistant, NDM-1 metallo--lactamase-producing Salmonella en-
terica serovar Agona from Pakistan. This study alerts toward possible risk of NDM-1 transmission to enteric fever pathogens
and encourages microbiologists to consider active screening of carbapenem resistance in nontyphoidal Salmonella isolates.
CASE REPORT
Case 1 is a 9-month-old child fromNosheroferoz, a small townin Sindh, Pakistan, who presented to Aga Khan Hospital, Ka-
rachi, with high-grade fever, vomiting, diarrhea, and abdominal
pain. Stool microscopy revealed 10 leukocytes (WBC)/low-power
field and mucous threads. The patient was admitted and started
on 10mg intravenous ciprofloxacin/kg of bodyweight twice a day.
The patient became afebrile after 2 days of treatment and was
discharged from the hospital on 10mg oral ciprofloxacin/kg twice
a day for 5 days. Stool culture yielded carbapenem-resistant Sal-
monella sp. (isolate 1a) that was susceptible only to azithromycin,
fosfomycin, and colistin. On the follow-up visit, the child was still
passing loose stools 5 or 6 times/day. A repeat stool culture yielded
a Salmonella sp. isolate (isolate 1b) with the same susceptibility
profile as the first. Treatment was changed to 250 mg oral fosfo-
mycin three times daily, and the patient finally improved.
Case 2 is a 1-year-old child from Karachi who was admitted to
the Aga Khan Hospital, Karachi, with history of diarrhea and
vomiting for 2 days. Stool microscopy revealed 20 WBC/low-
power field with mucous threads. The patient was admitted and
started on 65 mg intravenous ceftriaxone/kg once a day. Diarrhea
subsided within 3 days of admission, and the patient was dis-
charged on 10 mg oral ciprofloxacin/kg twice a day for 5 days.
Stool culture grew a carbapenem-resistant Salmonella sp. (isolate
2) susceptible only to azithromycin, fosfomycin, and colistin. This
patient had no further follow-up at our hospital.
Gastroenteritis caused by nontyphoidal Salmonella species
(NTS) is a major public health problem worldwide. Children less
than 2 years old are the main sufferers of enteritis caused by NTS
(1). The majority of these infections are self-limiting; therefore,
antimicrobial therapy is reserved for treatment of serious infec-
tions only. Some patients may develop prolonged enteritis, and
septicemia and extraintestinal complications aremore commonly
seen in immunocompromised and malnourished populations,
with an associated case fatality of 20 to 25% (2).
Diarrheal diseases are very common in Pakistan. Laboratory-
based surveillance data from our laboratory showed a 13% isola-
tion rate of enteric bacterial pathogens, including Campylobacter
spp., Salmonella spp., Shigella spp., andVibrio cholerae, from clin-
ically suspected cases of diarrhea (3). The frequency of isolation of
Salmonella spp. among stool pathogens is 18.4%, and it is the third
most commonly isolated enteric pathogen in our setting (4). Re-
ported rates of antimicrobial resistance in NTS vary geographi-
cally. Resistance also varies between different serotypes and differ-
ent antibiotics. Generally, low rates of resistance to ampicillin,
chloramphenicol, and ciprofloxacin have been reported in Salmo-
nella enterica serovar Enteritidis. In contrast, a higher rate of re-
sistance has been reported in S. enterica serovar Typhimurium (5).
With the emergence globally of ceftriaxone and quinolone resis-
tance in NTS, empirical therapy for severe gastroenteritis and in-
vasive infections has become challenging. Moreover, since the
emergence of the NDM metallo--lactamase enzyme in enteric
organisms, there has been a continuous threat of its spread into S.
enterica (6). Two cases of diarrhea caused by NDM-positive S.
enterica serovar Agona are presented in this report. A literature
search revealed few reports of carbapenem-resistant NTS; how-
ever, the genes identified were either blaKPC, blaIMP, or blaVIM (7,
8). In 2011 and 2012, two studies from the United States and
Reunion Island reported colonization with NDM-1-positive S.
enterica serovars Senftenberg and Westhampton, respectively;
however, the clinical significance of the reported isolateswas ques-
tionable (9). Only one clinically significant infection has been re-
ported, an NDM-1-producing S. enterica serovar Stanley from
China (10). Our report is the first report of clinically significant
NDM-1-producing S. enterica from the Indian subcontinent and
the first report of this enzyme in S. enterica serovar Agona.
Bacterial culture, identification, susceptibility testing, and pre-
liminary serotyping of all three isolates were performed at the
clinical laboratory of the Aga Khan University Hospital, while
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advance serotyping, PCR, sequencing, and pulsed-field gel elec-
trophoresis (PFGE) were performed at Public Health England’s
Salmonella Reference Section, United Kingdom. Samples were
processed by direct plating on MacConkey’s and xylose-lysine-
deoxycholate agar and inoculating selenite F broth as an enrich-
ment medium, which was subcultured the next day on Salmonella
and Shigella agar. Suspected colonies were identified by conven-
tional biochemical methods as Salmonella spp. and confirmed by
API 20E (bioMérieux, France). Initial serotyping of the isolates
revealed that all three isolates belonged to Salmonella group B.
Further serological identification was performed at Public Health
England’s Salmonella Reference Section, United Kingdom, and
isolates were identified as S. enterica serovar Agona (4,12:f,g,s:)
by using the Kauffmann-White scheme (11). Antimicrobial sus-
ceptibilities were performed by the disk diffusion method and
Vitek 2 Compact system (bioMérieux, France) and interpreted
according to Clinical and Laboratory Standards Institute guide-
lines (12), shown in Table 1. For azithromycin susceptibility, Brit-
ish Society of Antimicrobial and Chemotherapy breakpoints (13)
for S. enterica serovar Typhi were used. The multidrug resistance
pattern of these isolates is alarming, as the treatment options are
extremely limited. Both isolates were tested for other treatment
options, like azithromycin, fosfomycin, and colistin. Both chil-
dren received treatment for gastroenteritis; however, as the ma-
jority of diarrheal infections are self-limiting, treatment success
could not be evaluated.
All these isolates were tested for carbapenemase production by
using amodifiedHodge test (14) andwere also positive for blaNDM
PCR, using primers 5=-GGG CAG TCG CTT CCA ACG GT-3=
and 5=-GTA GTG CTC AGT GTC GGC AT-3= (15). Further con-
firmation for the presence of an NDM carbapenemase gene and
screening for extended-spectrum-beta-lactamase (ESBL) genes
were performed using the commercial Check-MDRCT102 ESBL-
carbapenemase microarray (Check-Points Health BV, Wagenin-
gen, The Netherlands), which detected NDM carbapenemase, a
group 1CTX-MESBL, and a non-ESBLTEMgene. Gene sequenc-
ing identified the NDM variant as NDM-1 in all three isolates. So
far, NDM-1 has also been reported in other diarrheal agents, like
Shigella spp. and Vibrio cholerae, from the Indian subcontinent,
from the environmental water samples with potential contamina-
tion from the sewage system (16). However, no NDM-1-positive
Shigella spp. and Vibrio cholerae have been reported from Paki-
stan. Similarly, this gene has not yet been identified in typhoidal
salmonellae. As the NDM-1 gene is already spreading in commu-
nity Enterobacteriaceae isolates, like Escherichia coli and Klebsiella
pneumoniae (4), there is real potential for this gene to spread into
enteric fever isolates.
When analyzed by pulsed-field gel electrophoresis, the three
isolates shared identical profiles, as shown in Fig. 1. Moreover, S.
enterica serovar Agona isolates of these two cases had similar an-
tibiograms, suggesting they originated from a common source.
However, because of the lack of laboratory-based data and active
surveillance of diarrheal diseases in the community, whether these
two isolates were part of a larger outbreak cannot be established.
This study alerts toward possible risk of NDM-1 transmission
to enteric fever pathogens and emphasizesmicrobiologists to con-
sider active screening of NTS isolates. Any carbapenem-resistant
isolates should be further investigated for the presence of NDM
enzymes and other carbapenemase genes. In addition, clinicians
are alerted to the emergence of these isolates, especially when
treating relapsing infections with Salmonella spp.
In conclusion, there is need for active surveillance and screen-
FIG 1 PFGE gel showing similarity of all three Salmonella enterica serovar
Agona isolates. To digest the DNA, restriction enzyme XbaI (New England
BioLabs) was used, and the following PFGE conditions were applied: 2 to 64 s
at 200 V for 22 h (17).
TABLE 1MIC of Salmonella enterica serovar Agona isolates 1a and 1b
(case 1) and isolate 2 (case 2), against various antibiotics determined by
the Vitek 2 Compact system
Antibiotic
MIC (g/ml)
Isolate 1a Isolate 1b Isolate 2
Ampicillin 32 32 32
Amoxicillin-clavulanic acid 32 32 32
Piperacillin-tazobactam 128 128 128
Ceftriaxone 64 64 64
Trimethoprim-sulfamethoxazole 320 320 320
Gentamicin 16 16 16
Ciprofloxacin 2 2 2
Imipenem 8 8 16
Meropenem 16 16 16
Colistin 0.5 0.5 0.5
Azithromycin 4 8 8
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ing of resistant Salmonella spp. in the region to avoid emergence of
NDM-1-positive typhoidal salmonella strains.
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